18F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials
出版年份 2016 全文链接
标题
18F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials
作者
关键词
<sup>18</sup>F-FDG PET/CT, Triple-negative breast cancer, HER2-positive breast cancer, Neoadjuvant treatment, Treatment response assessment, Pathological complete response, Prognosis
出版物
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 43, Issue 5, Pages 983-993
出版商
Springer Nature
发表日期
2016-01-14
DOI
10.1007/s00259-015-3295-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
- (2015) O. Humbert et al. CLINICAL CANCER RESEARCH
- Do clinical, histological or immunohistochemical primary tumour characteristics translate into different 18F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?
- (2015) David Groheux et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2- Breast Cancer
- (2015) D. Groheux et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen
- (2015) D. Groheux et al. JOURNAL OF NUCLEAR MEDICINE
- Pathological complete response in breast cancer
- (2015) Elif Hindié et al. LANCET
- Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype
- (2015) David Groheux et al. RADIOLOGY
- Oncogene Pathway Activation in Mammary Tumors Dictates FDG-PET Uptake
- (2014) J. V. Alvarez et al. CANCER RESEARCH
- Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer
- (2014) David Groheux et al. EUROPEAN JOURNAL OF CANCER
- Early and delayed prediction of axillary lymph node neoadjuvant response by 18F-FDG PET/CT in patients with locally advanced breast cancer
- (2014) Ana María García Vicente et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- HER2-positive breast cancer: 18F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy
- (2014) Olivier Humbert et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
- (2014) Ronald Boellaard et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- TBCRC 008: Early Change in 18F-FDG Uptake on PET Predicts Response to Preoperative Systemic Therapy in Human Epidermal Growth Factor Receptor 2-Negative Primary Operable Breast Cancer
- (2014) R. M. Connolly et al. JOURNAL OF NUCLEAR MEDICINE
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- Use of [18F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [18F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial
- (2014) Bruno Coudert et al. LANCET ONCOLOGY
- Predicting pathological complete response in breast cancer early
- (2014) David Groheux LANCET ONCOLOGY
- FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer
- (2013) Bas B. Koolen et al. BREAST
- HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment
- (2013) D Groheux et al. BRITISH JOURNAL OF CANCER
- Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer
- (2013) L S Rigter et al. BRITISH JOURNAL OF CANCER
- Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors
- (2013) David Groheux et al. CANCER
- Neoadjuvant Therapy as a Platform for Drug Development and Approval in Breast Cancer
- (2013) A. Bardia et al. CLINICAL CANCER RESEARCH
- Potential utility of early metabolic response by 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography/computed tomography in a selected group of breast cancer patients receiving preoperative chemotherapy
- (2013) G. Zucchini et al. EUROPEAN JOURNAL OF CANCER
- Sequential 18F-FDG PET/CT for early prediction of complete pathological response in breast and axilla during neoadjuvant chemotherapy
- (2013) Bas B. Koolen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using 18F-FDG PET in luminal HER2-negative breast cancer
- (2013) Olivier Humbert et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison Between 18F-FDG PET Image-Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2013) M. Hatt et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO
- (2013) G. Gebhart et al. JOURNAL OF NUCLEAR MEDICINE
- Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes
- (2012) O. Humbert et al. ANNALS OF ONCOLOGY
- Triple-Negative Breast Cancer: Early Assessment with 18F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse
- (2012) D. Groheux et al. JOURNAL OF NUCLEAR MEDICINE
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
- (2012) José Baselga et al. LANCET
- Neoadjuvant Chemotherapy in Breast Cancer: Prediction of Pathologic Response with PET/CT and Dynamic Contrast-enhanced MR Imaging—Prospective Assessment
- (2012) Ukihide Tateishi et al. RADIOLOGY
- Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis
- (2011) Yuting Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups
- (2011) Michael Untch et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
- (2011) Luca Gianni et al. LANCET ONCOLOGY
- Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast Cancer
- (2010) J. M. Specht et al. CLINICAL CANCER RESEARCH
- Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim
- (2010) David Groheux et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer
- (2010) David Groheux et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer
- (2009) A. Gil-Rendo et al. BRITISH JOURNAL OF SURGERY
- 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer
- (2009) Joan Duch et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
- (2009) Amandeep Kumar et al. EUROPEAN RADIOLOGY
- Tumor Metabolism and Blood Flow Changes by Positron Emission Tomography: Relation to Survival in Patients Treated With Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer
- (2008) Lisa K. Dunnwald et al. JOURNAL OF CLINICAL ONCOLOGY
- Preoperative Therapy in Invasive Breast Cancer: Pathologic Assessment and Systemic Therapy Issues in Operable Disease
- (2008) Julie R. Gralow et al. JOURNAL OF CLINICAL ONCOLOGY
- Monitoring Primary Systemic Therapy of Large and Locally Advanced Breast Cancer by Using Sequential Positron Emission Tomography Imaging With [18F]Fluorodeoxyglucose
- (2008) Jörg Schwarz-Dose et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started